Publications by authors named "Maria R Baer"

100Publications

Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report.

Cureus 2020 Sep 17;12(9):e10507. Epub 2020 Sep 17.

Departments of Medicine and Pediatrics, University of Maryland School of Medicine, Baltimore, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.10507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571590PMC
September 2020

Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

Pharmaceuticals (Basel) 2020 Jun 16;13(6). Epub 2020 Jun 16.

Departments of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ph13060124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345996PMC
June 2020

Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin.

Oncogene 2020 Apr 15;39(14):3015-3027. Epub 2020 Feb 15.

Division of Immunotherapy, Institute of Human Virology, Department of Surgery and Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-020-1201-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291851PMC
April 2020

Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.

Br J Haematol 2020 03 5;188(6):881-887. Epub 2019 Dec 5.

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16261DOI Listing
March 2020

An unusual presentation of paroxysmal nocturnal haemoglobinuria.

Br J Haematol 2020 02 21;188(3):347. Epub 2019 Nov 21.

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16250DOI Listing
February 2020

Gilteritinib or Chemotherapy for Relapsed or Refractory -Mutated AML.

N Engl J Med 2019 10;381(18):1728-1740

From the Abramson Cancer Center, University of Pennsylvania (A.E.P.), and Thomas Jefferson University (M.K.) - both in Philadelphia; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola (G.M.), L. and A. Seràgnoli Institute of Hematology, Bologna University Medical School, Bologna (S.P.), Ospedali Riuniti Villa Sofia-Cervello, Palermo (F.F.), and IRCCS San Raffaele Scientific Institute, Milan (F.C.) - all in Italy; University of Texas M.D. Anderson Cancer Center, Houston (J.E.C.); Universitätsklinikum Giessen und Marburg, Marburg, Germany (A.N.); Memorial Sloan Kettering Cancer Center, New York (E. Berman); Hospital Universitari i Politècnic La Fe, Valencia, and Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Instituto Carlos III, Madrid - both in Spain (P.M.); University of Maryland Greenebaum Comprehensive Cancer Center (M.R.B.) and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University (M.J.L.) - both in Baltimore; University of Chicago, Chicago (R.A.L.), and Astellas Pharma, Northbrook (C.L., N. Hasabou, X.L., E. Bahceci) - both in Illinois; University of Minnesota, Minneapolis (C.U.); University of Alabama at Birmingham, Birmingham (H.P.E., A.D.S.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.S.); University of California, San Francisco, San Francisco (R.O.); National Taiwan University, Taipei City, Taiwan (W.-C.C.); Yale University School of Medicine, New Haven, CT (N.P.); Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France (C.R.); Sendai Medical Center, National Hospital Organization, Sendai (H.Y.), and University of Fukui, Fukui (N. Hosono) - both in Japan; Seoul National University (S.-S.Y.) and Asan Medical Center, University of Ulsan College of Medicine (J.-H.L.) - both in Seoul, South Korea; Wake Forest Baptist Medical Center, Winston-Salem, NC (T.P.); and Massachusetts General Hospital, Harvard Medical School, Boston (A.T.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902688DOI Listing
October 2019

Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma.

Leuk Lymphoma 2019 12 8;60(14):3577-3580. Epub 2019 Jul 8.

Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1633639DOI Listing
December 2019

An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.

JMIR Mhealth Uhealth 2019 06 20;7(6):e13501. Epub 2019 Jun 20.

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, University of Maryland, Baltimore, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/13501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610466PMC
June 2019

Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.

Acta Haematol 2019 20;142(4):233-238. Epub 2019 May 20.

Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000500223DOI Listing
March 2020

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

Cancer Chemother Pharmacol 2019 06 9;83(6):1105-1112. Epub 2019 Apr 9.

School of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, 22 S. Greene St., Room N9E24, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03825-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334867PMC
June 2019

Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD.

Cancer Lett 2019 07 4;454:171-178. Epub 2019 Apr 4.

Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, 21201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2019.03.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528833PMC
July 2019

Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.

J Oncol Pharm Pract 2020 Jan 27;26(1):74-92. Epub 2019 Mar 27.

Division of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219838316DOI Listing
January 2020

Babesiosis Masquerading as Evans Syndrome.

Am J Med 2019 07 20;132(7):e616-e617. Epub 2019 Mar 20.

Department of Medicine, University of Maryland School of Medicine, Baltimore, Md; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Md.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2019.02.041DOI Listing
July 2019

Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.

Adv Cancer Res 2019 21;141:213-253. Epub 2019 Jan 21.

Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.acr.2018.12.005DOI Listing
April 2020

Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab.

Am J Hematol 2019 01 25;94(1):E7-E8. Epub 2018 Nov 25.

Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25317DOI Listing
January 2019

Evaluation of an alternative ruxolitinib dosing regimen in patients with myelofibrosis: an open-label phase 2 study.

J Hematol Oncol 2018 08 7;11(1):101. Epub 2018 Aug 7.

University of Maryland, Greenebaum Comprehensive Cancer Center, 22 S. Greene St, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-018-0642-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081850PMC
August 2018

Sickle Cell Disease Complicated by Iron Overload: An Under-Recognized Risk Factor for Vibrio vulnificus Infection.

Acta Haematol 2018;139(3):199-200. Epub 2018 May 7.

University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488754DOI Listing
March 2019

Acute Onset Unilateral Proptosis.

Am J Med 2018 08 13;131(8):e337-e338. Epub 2018 Apr 13.

University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore; Department of Medicine, University of Maryland School of Medicine, Baltimore. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.03.021DOI Listing
August 2018

Thrombotic microangiopathy in the setting of human immunodeficiency virus infection: High incidence of severe thrombocytopenia.

J Clin Apher 2018 Jun 26;33(3):342-348. Epub 2018 Jan 26.

Division of Hematology/Oncology, Department of Medicine, University of Maryland, School of Medicine, 22 South Greene Street, Baltimore, Maryland, 21201.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jca.21615
Publisher Site
http://dx.doi.org/10.1002/jca.21615DOI Listing
June 2018

Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura.

Am J Hematol 2018 03 10;93(3):E77-E79. Epub 2018 Jan 10.

Division of Hematology-Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25007DOI Listing
March 2018

FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.

Mol Cancer Ther 2017 06;16(6):991-1001

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600895PMC
June 2017

Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.

Cancer Genet 2017 04 27;212-213:38-44. Epub 2017 Mar 27.

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2017.03.004DOI Listing
April 2017

Isolated thrombocytopenia and liver function abnormalities characterizing an atypical presentation of thrombotic thrombocytopenic purpura.

Ann Hematol 2016 Dec 20;95(12):2079-2080. Epub 2016 Aug 20.

Division of Hematology-Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2797-5DOI Listing
December 2016

Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis.

Transfus Apher Sci 2017 Apr 17;56(2):123-126. Epub 2016 Oct 17.

Division of Hematology/Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, 22 South Greene Street, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2016.10.005DOI Listing
April 2017

Concomitant amplification of the MLL gene on a ring chromosome and a homogeneously staining region (hsr) in acute myeloid leukemia: mechanistic implications.

Leuk Lymphoma 2017 05 12;58(5):1250-1253. Epub 2016 Oct 12.

a Department of Pathology , University of Maryland School of Medicine , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1233539DOI Listing
May 2017

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer.

Cancer Cell 2016 10;30(4):637-650

Department of Radiation Oncology, University of Maryland, Baltimore, MD 21201, USA; University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201166PMC
October 2016

Development of Hypercalcemia in a Patient Receiving Peginterferon alfa-2a Therapy for Polycythemia Vera.

Pharmacotherapy 2016 Jun 8;36(6):e54-e57. Epub 2016 Jun 8.

Department of Medicine and Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1767DOI Listing
June 2016

Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment.

Mol Cancer Ther 2016 Mar 28;15(3):392-401. Epub 2016 Jan 28.

Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783244PMC
March 2016

Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes.

J Comp Eff Res 2015 Aug;4(4):327-40

Department of Health Policy & Management, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer.15.20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549705PMC
August 2015

c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.

Mol Cancer Res 2015 Apr 31;13(4):699-712. Epub 2015 Mar 31.

Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland. Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398615PMC
April 2015

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.

J Oncol Pharm Pract 2016 Apr 23;22(2):374-7. Epub 2015 Jan 23.

Department of Medicine, University of Maryland School of Medicine, Baltimore, USA Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155214568582DOI Listing
April 2016

The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations.

Invest New Drugs 2015 Apr 20;33(2):300-9. Epub 2015 Jan 20.

University of Maryland Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0205-yDOI Listing
April 2015

Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part D.

J Oncol Pract 2015 Mar 6;11(2):e190-8. Epub 2015 Jan 6.

Yale School of Public Health, Yale University; Yale Cancer Center, Yale School of Medicine, New Haven, CT; University of Maryland School of Pharmacy; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD; and US Health Outcomes and Medical Policy, GlaxoSmithKline, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371123PMC
March 2015

Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes.

Medicare Medicaid Res Rev 2014 26;4(4). Epub 2014 Nov 26.

University of Maryland, School of Medicine-Greenebaum Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5600/mmrr.004.04.a02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254334PMC
September 2016

High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplication.

Cancer Genet 2014 Oct-Dec;207(10-12):467-73. Epub 2014 Sep 16.

University of Maryland Greenebaum Cancer Center, Baltimore, MD; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2014.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486681PMC
February 2015

Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.

Oncol Rep 2014 Apr 28;31(4):1605-12. Epub 2014 Jan 28.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2014.3002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975990PMC
April 2014

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.

J Clin Oncol 2014 Feb 30;32(6):548-56. Epub 2013 Dec 30.

Guido Marcucci, Pearlly Yan, Kati Maharry, David Frankhouser, Deedra Nicolet, Klaus H. Metzeler, Jessica Kohlschmidt, Krzysztof Mrózek, Yue-Zhong Wu, Donna Bucci, John P. Curfman, Susan P. Whitman, Ann-Kathrin Eisfeld, Jason H. Mendler, Sebastian Schwind, Heiko Becker, John C. Byrd, Ramiro Garzon, Michael A. Caligiuri, Stefano Volinia, and Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center; Ralf Bundschuh, The Ohio State University, Columbus, OH; Kati Maharry, Deedra Nicolet, and Jessica Kohlschmidt, Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, MN; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Maria R. Baer, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Meir Wetzler, Roswell Park Cancer Institute, Buffalo; Jonathan E. Kolitz, Monter Cancer Center, Lake Success, NY; Thomas H. Carter, University of Iowa, Iowa City, IA; Bayard L. Powell, The Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC; Richard M. Stone, Dana-Farber Cancer Institute, Boston, MA; Constance Bär and Christoph Plass, German Cancer Research Center, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.6337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918538PMC
February 2014

Unbalanced 11;18 translocation in an acute erythroid leukemia after radioactive iodine therapy.

Cancer Genet 2013 Jun 18;206(6):252-5. Epub 2013 Jul 18.

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2013.06.003DOI Listing
June 2013

Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemia.

Leuk Lymphoma 2014 Mar 10;55(3):680-2. Epub 2013 Jul 10.

Department of Pathology, Johns Hopkins University , Baltimore, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.809076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251429PMC
March 2014

Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.

Cancer 2013 Aug 30;119(15):2720-7. Epub 2013 Apr 30.

Division of Hematology/Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821042PMC
August 2013

Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines.

Leuk Res 2013 Jun 21;37(6):675-80. Epub 2013 Mar 21.

Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD 20850, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.02.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694576PMC
June 2013

Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice.

Int J Hematol 2013 Apr 5;97(4):456-64. Epub 2013 Mar 5.

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, 1275 York Ave.,New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-013-1275-2
Publisher Site
http://dx.doi.org/10.1007/s12185-013-1275-2DOI Listing
April 2013

Rituximab maintenance therapy until progression after rituximab and chemotherapy induction in patients with follicular lymphoma.

Clin Lymphoma Myeloma Leuk 2013 Jun 24;13(3):253-7. Epub 2013 Jan 24.

University of Maryland, Greenebaum Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650120029
Publisher Site
http://dx.doi.org/10.1016/j.clml.2012.12.011DOI Listing
June 2013

Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.

J Clin Oncol 2013 Mar 14;31(7):e98-100. Epub 2013 Jan 14.

University of Maryland Medical Center, 22 South Greene St N3E09, Baltimore MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.9489DOI Listing
March 2013

The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies.

Blood 2013 Jan 16;121(2):329-38. Epub 2012 Nov 16.

Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-06-436691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544115PMC
January 2013

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.

Haematologica 2013 Apr 9;98(4):584-90. Epub 2012 Nov 9.

Division of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.haematologica.org/cgi/doi/10.3324/haematol.2012.0
Publisher Site
http://dx.doi.org/10.3324/haematol.2012.062547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659989PMC
April 2013

The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.

Mol Cancer Ther 2012 Sep 9;11(9):2033-44. Epub 2012 Jul 9.

University of Maryland Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683995PMC
September 2012

Drug resistance: still a daunting challenge to the successful treatment of AML.

Drug Resist Updat 2012 Feb-Apr;15(1-2):62-9. Epub 2012 Mar 11.

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2012.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348380PMC
August 2012

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Biochem Pharmacol 2012 Apr 11;83(8):1084-103. Epub 2012 Jan 11.

University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2012.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307098PMC
April 2012

Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes.

Haematologica 2012 Jan;97(1):128-32

Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.049130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248941PMC
January 2012